Interventional treatment for fetus and newborn infant with congenital heart disease

G Satomi1, S Yasukochi, T Imai

  • 1Department of Pediatric Cardiology, Nagano Children's Hospital, Nagano, Japan. gsatomi@naganoch.gr.jp

Insights

Early catheter interventions for congenital heart disease in newborns are effective. This study highlights successful neonatal balloon valvuloplasty for critical aortic stenosis and early delivery for ductus arteriosus constriction.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Neonatal Medicine

Background:

  • Catheter interventions are increasingly used for congenital heart disease in pediatric patients.
  • Early neonatal catheter interventions are being explored, aided by advances in prenatal diagnosis.
  • Prenatal diagnosis enables timely intervention for severe neonatal cardiac conditions.

Purpose of the Study:

  • To review current cardiac interventional treatments for neonates.
  • To discuss the application of these treatments during the perinatal period.
  • To explore future prospects in perinatal cardiac interventions.

Main Methods:

  • Review of recent literature on severe structural cardiac diseases in newborns.
  • Consideration of conditions like critical aortic stenosis and ductus arteriosus constriction.
  • Presentation of case experiences with neonatal interventions.

Main Results:

  • Successful early neonatal balloon valvuloplasty for critical aortic stenosis post-prenatal diagnosis.
  • Management of premature ductus arteriosus constriction via early delivery to prevent pulmonary hypertension.
  • Demonstration of effective perinatal cardiac interventions.

Conclusions:

  • Perinatal cardiac interventions are feasible and beneficial for specific neonatal conditions.
  • Early diagnosis and intervention improve outcomes for critical congenital heart disease.
  • The field of perinatal cardiology shows promising future developments.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...